Articles
| Open Access |
https://doi.org/10.55640/
THE USE OF DEXMEDETOMIDINE HYDROCHLORIDE IN MULTIMODAL ANESTHESIA FOR CESAREAN SECTION IN PREGNANT WOMEN WITH PREECLAMPSIA
Usmanov Bobir Kurbonbayevich,Abidov Azamat Kadirberganovich , 1.Doctor of the Intensive Care Unit, Chortoq District Medical Association, Namangan Region 2.Place of work: State Institution “Republican Specialized Scientific and Practical Medical Center for Maternal and Child Health”Abstract
Preeclampsia is a significant obstetric complication associated with maternal and fetal morbidity and mortality. Cesarean section remains a common delivery method in women with preeclampsia due to maternal or fetal indications. Effective anesthetic management is crucial for ensuring hemodynamic stability and minimizing perioperative complications. Multimodal anesthesia, incorporating agents like dexmedetomidine hydrochloride, has shown promise in enhancing analgesia, reducing opioid consumption, and providing stable cardiovascular control. This study evaluates the clinical effectiveness and safety of dexmedetomidine in multimodal anesthesia for cesarean sections in preeclamptic patients.
Keywords
Preeclampsia; Cesarean Section; Multimodal Anesthesia; Dexmedetomidine Hydrochloride; Hemodynamic Stability; Perioperative Analgesia.
References
Roberts, J. M., & Cooper, D. W. (2001). Pathogenesis and genetics of pre-eclampsia. Lancet, 357(9249), 53–56.
Sibai, B. M. (2003). Diagnosis, prevention, and management of preeclampsia. Obstetrics & Gynecology, 102(1), 181–192.
Haththotuwa, R., et al. (2015). Anesthetic management of cesarean delivery in preeclampsia. International Journal of Obstetric Anesthesia, 24(2), 110–118.
Gerlach, A. T., & Dasta, J. F. (2007). Dexmedetomidine: An updated review. Annals of Pharmacotherapy, 41(2), 245–252.
Venn, R. M., et al. (2000). Cardiovascular effects of dexmedetomidine in humans. British Journal of Anaesthesia, 84(1), 1–8.
Choi, S. H., et al. (2016). Multimodal analgesia in cesarean section: Effects on opioid consumption. Korean Journal of Anesthesiology, 69(4), 361–368.
Maze, M., & Tranquilli, W. (1991). Alpha-2 adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology, 74(3), 581–605.
Bhattacharjee, D., et al. (2015). Dexmedetomidine in cesarean delivery: Hemodynamic effects and postoperative analgesia. Journal of Obstetric Anaesthesia, 25(1), 30–36.
Gao, X., et al. (2019). Intravenous dexmedetomidine as an adjuvant to neuraxial anesthesia for cesarean section: A randomized trial. BMC Anesthesiology, 19(1), 204.
Mohamed, A. M., et al. (2017). Dexmedetomidine infusion for perioperative analgesia in preeclamptic patients undergoing cesarean delivery. Saudi Journal of Anaesthesia, 11(2), 178–183.
Talke, P., et al. (1997). Sedative, analgesic, and respiratory effects of dexmedetomidine in humans. Anesthesia & Analgesia, 85(2), 515–520.
Li, A., et al. (2018). Hemodynamic effects of dexmedetomidine infusion during cesarean section. Medicine (Baltimore), 97(23), e10930.
Dahaba, A. A., et al. (2011). Maternal and fetal safety of dexmedetomidine in cesarean delivery. European Journal of Anaesthesiology, 28(11), 869–873.
Sun, Y., et al. (2020). Dexmedetomidine as adjuvant in multimodal anesthesia for cesarean section. Frontiers in Medicine, 7, 577–584.
Lee, H., et al. (2019). Effects of maternal dexmedetomidine on neonatal outcomes: A prospective observational study. Journal of Maternal-Fetal & Neonatal Medicine, 32(11), 1801–1808.
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.